Catalyst Pharmaceuticals, Inc.
Short
Updated

CPRX didnt cataylze anything

60
weekly data, regression analysis hit upper band, major candle stick wick.. blow that candle out! due to offering 8 million new shares diluting value.
FIB can retrace back to $2.5 if we arent careful, already did a month ago [ nice arbitrage $$].

On the medical side the product does have staying power, just a matter of selling it, expensive price tag though. 1st in class

As per the stock, buy low sell high, the option calls Dec 2019 have it at $10.

Ride the roller coaster my friends.

cheers , happy trading!
Note
Reverse course.. company holds off [24hr later] NOT issuing 8mill new stock.. after a more than not appreciative [tanked 18%] response.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.